|
05/11/2024
|
07:00
|
New Patent Application and Trading Update
|
RNS
|
|
15/10/2024
|
10:28
|
Holding(s) in Company
|
RNS
|
|
14/10/2024
|
12:08
|
Holding(s) in Company
|
RNS
|
|
14/10/2024
|
12:05
|
PDMR dealing and TR1 announcement
|
RNS
|
|
11/10/2024
|
10:42
|
Acquisition of Interest by Braveheart
|
RNS
|
|
25/06/2024
|
09:59
|
IB Opens Expanded Access Program
|
RNS
|
|
14/06/2024
|
08:38
|
Clinical Trial Updates
|
RNS
|
|
29/05/2024
|
15:08
|
Result of AGM
|
RNS
|
|
23/05/2024
|
07:00
|
Major East Coast Health System Chooses IB Nimble
|
RNS
|
|
20/05/2024
|
07:10
|
Second FDA Rare Pediatric Disease Designation
|
RNS
|
|
17/05/2024
|
07:00
|
IB Software Enhances Clinical Decision-Making
|
RNS
|
|
10/05/2024
|
08:15
|
Rare Pediatric Disease Designation Granted to GaM
|
RNS
|
|
02/05/2024
|
12:47
|
IB Announces Expanded Access Program for GaM
|
RNS
|
|
29/04/2024
|
15:26
|
Publication of Annual Report
|
RNS
|
|
05/03/2024
|
07:00
|
Grant of Options
|
RNS
|
|
01/03/2024
|
08:22
|
Holding(s) in Company
|
RNS
|
|
01/03/2024
|
08:20
|
Holding(s) in Company
|
RNS
|
|
26/02/2024
|
07:00
|
Result of Broker Option and Total Voting Rights
|
RNS
|
|
22/02/2024
|
07:00
|
Placing and Broker Option
|
RNS
|
|
09/02/2024
|
12:49
|
FDA Application Update
|
RNS
|
|
02/02/2024
|
08:39
|
IB awarded a $100,000 grant
|
RNS
|
|
22/01/2024
|
10:05
|
Holding(s) in Company
|
RNS
|
|
15/01/2024
|
07:01
|
Director Dealings and Conversion of CLNs
|
RNS
|
|
15/01/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
10/01/2024
|
07:00
|
IB Launching an Expanded Access Program for GaM
|
RNS
|
|
19/12/2023
|
14:29
|
Imaging Biometrics granted FDA “Fast-Trackâ€
|
RNS
|
|
05/12/2023
|
10:58
|
IQ-AI Announces Positive Interim Phase 1 Results
|
RNS
|
|
20/11/2023
|
13:42
|
Holding(s) in Company
|
RNS
|
|
09/11/2023
|
11:38
|
Director Dealing and Conversion of CLNs
|
RNS
|
|
08/11/2023
|
10:59
|
Application for Pediatric Rare Disease Designation
|
RNS
|
|
06/11/2023
|
13:02
|
Holding(s) in Company
|
RNS
|
|
18/10/2023
|
14:29
|
Update Regarding Imaging Biometrics LLC
|
RNS
|
|
13/10/2023
|
08:55
|
IB Letter to Shareholders
|
RNS
|
|
09/10/2023
|
07:00
|
Orphan Drug Status to GaM and Total Voting Rights
|
RNS
|
|
03/10/2023
|
11:30
|
Holding(s) in Company
|
RNS
|
|
19/09/2023
|
14:32
|
IQ-AI shares cease trading on the OTCQB
|
RNS
|
|
08/09/2023
|
07:00
|
Reduced Gadolinium Approach Validated'
|
RNS
|
|
18/08/2023
|
12:06
|
Update on Collaboration Agreement with Mayo Clinic
|
RNS
|
|
18/08/2023
|
11:20
|
IB & GE HealthCare Enter into Commercial Agreement
|
RNS
|
|
17/08/2023
|
07:00
|
Half-year Report
|
RNS
|
|
13/07/2023
|
07:00
|
Orphan Drug Designation for GaM in Pediatric GBM
|
RNS
|
|
23/05/2023
|
11:02
|
Result of AGM
|
RNS
|
|
23/05/2023
|
07:00
|
AGM Statement
|
RNS
|
|
03/05/2023
|
16:14
|
Notice of AGM
|
RNS
|
|
26/04/2023
|
07:00
|
Final Results
|
RNS
|
|
28/02/2023
|
15:52
|
Orphan Drug Designation Status
|
RNS
|
|
13/01/2023
|
14:05
|
Second Price Monitoring Extn
|
RNS
|
|
13/01/2023
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
13/01/2023
|
11:05
|
Second Price Monitoring Extn
|
RNS
|
|
13/01/2023
|
11:00
|
Price Monitoring Extension
|
RNS
|